CLINICAL_TRIALS ClinicalTrials.gov record update

Phase I/II Trial Evaluating the Safety and Efficacy of Ruxolitinib in Subjects With Smoldering and Chronic Adult T-cell Leukemia (ATL)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT01712659
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:38:50.743383+00:00
Published At: 2023-01-10T00:00:00+00:00
Record Updated At: 2023-01-10
Results Posted At: 2023-01-10
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["T Cell Leukemia, Adult", "Leukemia, Adult T-Cell", "T Cell Leukemia, HTLV I Associated"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2023-01-10"
protocolSection.identificationModule.nctId: "NCT01712659"
protocolSection.identificationModule.officialTitle: "Phase I/II Trial Evaluating the Safety and Efficacy of Ruxolitinib in Subjects With Smoldering and Chronic Adult T-cell Leukemia (ATL)"
protocolSection.statusModule.overallStatus: "TERMINATED"
protocolSection.designModule.phases: ["PHASE1", "PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2023-01-10"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.